Breaking News, Financial News

Financial Report: WuXi PharmaTech

Revenues up 9% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech

2Q Revenues: $142.3 million (+9%)

2Q Earnings: $29.6 million (+45%)

YTD Revenues: $274.2 million (+10%)

YTD Earnings: $51.3 million (+24%)

Comments: Laboratory Services revenue was up 13% to $105.9 million in the quarter. China-based Lab Services revenue was up 19% to $83.4 million. U.S.-based Lab Services revenue was down 3% to $22.5 million. Manufacturing Services revenue was $36.4 million, down 1%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters